Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.

American journal of public health - 1 Sept 1995

Mayeux R, Schupf N

Abstract excerpt

We review the current status as well as the risks and benefits of a recently developed DNA test of risk for Alzheimer's disease: the apolipoprotein E genotype. While apolipoprotein E genotypes may indicate a degree of susceptibility, the gene is neither necessary nor sufficient to cause the disease; thus, many questions remain. Because risk prediction is not straightforward, practical issues related to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Apolipoproteins E
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Genotype

Share to Risk Assessment

Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 7661240
DOI: 10.2105/ajph.85.9.1280
PMCID: PMC1615571

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.PMID 7661240Read ↗

Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.Semantic proximity Read ↗

A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease.Semantic proximity Read ↗

Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences.Semantic proximity Read ↗

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E genotype and Alzheimer's diseaseSemantic proximity Read ↗

Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseSemantic proximity Read ↗

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapySemantic proximity Read ↗

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approachesSemantic proximity Read ↗

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.Semantic proximity Read ↗

Apolipoprotein E genotype: utility in clinical practice in Alzheimer's disease.Semantic proximity Read ↗

Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease.Semantic proximity Read ↗

The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.